Logo

Daniel Swan

Mar 16, 2015

Daniel Swan has joined The Genome Analysis Center (TGAC) as head of the platform and pipelines group, where he will be responsible for the research institute's suite of advanced genome analysis facilities.

Previously, Swan headed NGS analysis at Oxford Gene Technology and was responsible for developing NGS products and services for academic, commercial, and clinical research customers. He also has worked at the National Environmental Research Council's environmental bioinformatics center, and he ran Newcastle University's bioinformatics core facility.

Swan trained as a vertebrate developmental biologist at Imperial College London and Edinburgh University before transitioning into bioinformatics with a post at Barts and the London Genome Center. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.